These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6735787)

  • 41. Quality assurance issues in conducting multi-institutional advanced technology clinical trials.
    Purdy JA
    Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S66-70. PubMed ID: 18406941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality assurance of serial tomotherapy for head and neck patient treatments.
    Low DA; Chao KS; Mutic S; Gerber RL; Perez CA; Purdy JA
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):681-92. PubMed ID: 9806530
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care.
    Ishikura S
    Jpn J Clin Oncol; 2008 Nov; 38(11):723-9. PubMed ID: 18952706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A quality control program for radiotherapy in Hodgkin's disease].
    Hennequin C; Carrié C; Hofstetter S; Cosset JM
    Cancer Radiother; 1999; 3(2):187-90. PubMed ID: 10230379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
    Sause WT; Scott C; Taylor S; Johnson D; Livingston R; Komaki R; Emami B; Curran WJ; Byhardt RW; Turrisi AT
    J Natl Cancer Inst; 1995 Feb; 87(3):198-205. PubMed ID: 7707407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initial clinical experience performing patient treatment verification with an electronic portal imaging device transit dosimeter.
    Berry SL; Polvorosa C; Cheng S; Deutsch I; Chao KS; Wuu CS
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):204-9. PubMed ID: 24210671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survey of tangential field planning and dose distribution in the UK: background to the introduction of the quality assurance programme for the START trial in early breast cancer.
    Winfield EA; Deighton A; Venables K; Hoskin PJ; Aird EG;
    Br J Radiol; 2003 Apr; 76(904):254-9. PubMed ID: 12711645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality assurance in radiotherapy: physical and technical aspects.
    Mijnheer BJ
    Qual Assur Health Care; 1992 Mar; 4(1):9-18. PubMed ID: 1576339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours - a clinical physics perspective.
    Lambrecht M; Melidis C; Sonke JJ; Adebahr S; Boellaard R; Verheij M; Guckenberger M; Nestle U; Hurkmans C
    Radiat Oncol; 2016 Jan; 11():7. PubMed ID: 26791788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.
    Willett CG; Moughan J; O'Meara E; Galvin JM; Crane CH; Winter K; Manfredi D; Rich TA; Rabinovitch R; Lustig R; Machtay M; Curran WJ
    Radiother Oncol; 2012 Oct; 105(1):9-13. PubMed ID: 23084596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of initial quality control review on study outcome in lung and head/neck cancer studies--review of the Radiation Therapy Oncology Group experience.
    Wallner PE; Lustig RA; Pajak TF; Robinson G; Davis LW; Perez CA; Seydel HG; Marcial VA; Laramore GE
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):893-900. PubMed ID: 2674086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intensity-modulated radiotherapy: current status and issues of interest.
    Intensity Modulated Radiation Therapy Collaborative Working Group
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):880-914. PubMed ID: 11704310
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Quality criteria of thoracic radiotherapy. Application to clinical research].
    Girard N; Mornex F
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S87-93. PubMed ID: 18235399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient-specific quality assurance for the delivery of (60)Co intensity modulated radiation therapy subject to a 0.35-T lateral magnetic field.
    Li HH; Rodriguez VL; Green OL; Hu Y; Kashani R; Wooten HO; Yang D; Mutic S
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):65-72. PubMed ID: 25442343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
    Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
    Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dose escalation for non-small cell lung cancer using conformal radiation therapy.
    Robertson JM; Ten Haken RK; Hazuka MB; Turrisi AT; Martel MK; Pu AT; Littles JF; Martinez FJ; Francis IR; Quint LE; Lichter AS
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1079-85. PubMed ID: 9169816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
    Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
    J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An external dosimetry audit programme to credential static and rotational IMRT delivery for clinical trials quality assurance.
    Eaton DJ; Tyler J; Backshall A; Bernstein D; Carver A; Gasnier A; Henderson J; Lee J; Patel R; Tsang Y; Yang H; Zotova R; Wells E
    Phys Med; 2017 Mar; 35():25-30. PubMed ID: 28236559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biological, physical factors in clinical assessment of outcome of cancer therapy.
    Perez CA
    Rays; 2005; 30(2):85-98. PubMed ID: 16294900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.